Interestingly, despite a beneficial effect of the (otherwise liver-toxic) PPARγ agonist troglitazone was reported in the unilateral ureter obstruction (UUO) model of renal fibrosis [20], others could not confirm these results using pioglitazone [21]. Here, PPARG is linked to renal fibrosis.